1. Market Research
  2. > Biotechnology

Biotech Industry Outlook: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
12 votes

Global Biotechnology Industry

The global biotechnology industry is forecast to exceed $320 billion by 2015, reports Global Industry Analysts. Market growth is fuelled by economic recovery, increased R&D funding, government initiatives and biotechnology used in agriculture and medical sciences. Developing nations, particularly China and India, are becoming major markets in the fields of agricultural and industrial biotechnology.

The economic crisis negatively impacted the biotechnology market, and brought about revenue declines in the US and the EU as a result of limited capital inflows and the delay or cancellation of projects. The market has entered a phase of recovery, with many large biotechnology outfits generating revenue thanks to new cost-savings and efficiency measures.

Industry funding is on the rise on the back of more favorable economic conditions, though this funding is concentrated in a small number of larger outfits. Smaller companies are still struggling to raise R&D funds. The situation is likely to improve as venture capitalists exercise greater caution in seeking more secure investment options.

Biotech Key Market Segments

Biological Therapy - The biotechnology industry was further segmented in 2011, steered away from its traditional drug focus and into other fields, including cleantech and chemical manufacturing. BCC Research points to the focus on funding in low-possibility-of-success (POS) areas, such as antineoplastic and immunomodulating agents over other fields with greater success potential such as dermatology or acute diseases.

Genetic Testing represents an important market if we consider diagnosis as the key to better quality healthcare. This segment involves testing for chromosome, protein and gene abnormality or changes linked with inherited medical conditions. The global genetic testing industry is in a period of strong growth, fuelled by rising numbers of genetic disorders, better awareness and an aging population. The market was worth $1.5 billion in 2010, reports RNCOS.

The world genetic testing (and genomics) market is expected to reach $4 billion by 2015. Genetic testing for cancer is likely to experience one of the highest growth rates, receiving particular interest from the private sector and the scientific community at large. Direct-to-consumer genetic testing is a market segment that is likely to take off, with many new outfits on the market. Market shapers include 23andme and deCODE.

Biopharmaceuticals - Global enzyme demand is expected to grow, with the market expected to exceed $7.5 billion in 2010, according to Freedonia. The majority of markets are forecast to record yearly growth in of more than 5%, except for biofuel production and certain other smaller industrial enzyme segments. Regional growth rates will be highest in markets like the Africa/Mideast region, and Central and South America. Growth will be comparatively lower in established economies such as the US and the EU. Enzyme demand in North America will be negatively impacted by a slow switch over to biomass-based biofuel production. EU enzyme demand will be negatively impacted by the EU debt crisis.

Biotech Industry Regional Market Share

The US dominates the global biotechnology industry, followed by developed EU nations such as Germany, Spain, France and the UK, reports Global Industry Analysts. Developing nations like China and India are likely to record strong growth in agricultural and industrial biotechnology industries due to rising income levels and population. Both countries are playing an increasingly significant role in the biotech drugs market on the back of relatively low-cost investment and a high level of expertise.

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 14000 reports

Global Biotechnology Industry

  • November 2016
    22 pages
  • Biotechnology  

    Biotech  

  • World  

View report >

Biotechnology Industry in Australia and the US

  • May 2017
    6 pages
  • Biotechnology  

  • Australia  

    United States  

View report >

Animal Biotechnology Industry in Europe

  • May 2017
    22 pages
  • Animal Biotechn...  

  • Europe  

    United States  

    Denmark  

View report >

Biotechnology Industry in Australia and Japan

  • March 2015
    5 pages
  • Biotechnology  

  • Australia  

    Japan  

View report >

The future of the Biotechnology Industry in France

  • January 2017
    6 pages
  • Biotechnology  

  • France  

View report >

Biotechnology Statistics in Germany and Europe

  • February 2017
    68 pages
  • Germany  

    Europe  

    World  

View report >

Biotechnology Industry in Italy - Forecast

  • December 2016
    26 pages
  • Biotech  

    Industrial Biot...  

    Biotechnology  

  • Italy  

    Europe  

View report >

Biotechnology Industry in the UK

  • August 2016
    80 pages
  • United Kingdom  

    Europe  

    Netherlands  

View report >

Plant Biotechnology Industry in Canada

  • April 2017
    18 pages
  • Crop Production  

    Plant Biotechno...  

  • Canada  

    United States  

View report >

Biotechnology Industry in Brazil

  • September 2016
    9 pages
  • Biotechnology  

  • Brazil  

    South America  

View report >

Search in Biotechnology Industry (About 14000 reports)
Related markets: Crop Production, Farming, Soybean, Fish, Grain, Genetic, Protein, Cell Therapy, Biosimilar, Biotech, DNA, GMO, Enzyme, Genome Sequencing, Cytogenetic, Stem Cell, Plant Biotechnology

About 2000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 9504)

Market Research of Microalgae DHA in China

  • $ 9504
  • Industry report
  • April 2017
  • by CCM Information Science & Technology Co., Ltd

Microalgae DHA has been developing in China for more than 10 years. With a growing concern for health by Chinese people, microalgae DHA as a healthful food additive has become more and more popular in ...

Biosimilars Market Access In The U.s.

March 2017 $ 7500

Biosimilars Market Access In Psoriasis

March 2017 $ 7500

Frontier Pharma: Fatty Liver Disease - High Degree Of F ...

March 2017 $ 6995

Frontier Pharma: Head And Neck Cancer - Immunotherapies ...

March 2017 $ 6995

Separation Systems For Commercial Biotechnology

March 2017 $ 6650

Medical Laboratory Testing Services Including Cardiac, ...

April 2017 $ 5995

In Vitro Diagnostic Testing Services Including Cardiac, ...

April 2017 $ 5995

Clinical Laboratory, Cardiac, Molecular Diagnostics And ...

April 2017 $ 5995

Single-use Bioprocessing Systems Market - Asia Pacific ...

April 2017 $ 5795

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.